Engineers Build World’s Smallest, Fastest Nanomotor

Researchers at the Cockrell School of Engineering at The University of Texas at Austin have built the smallest, fastest and longest-running tiny synthetic motor to date. The team’s nanomotor is an important step toward developing miniature machines that could one day move through the body to administer insulin for diabetics when needed, or target and treat cancer cells without harming good cells.

With the goal of powering these yet-to-be invented devices, UT Austin engineers focused on building a reliable, ultra-high-speed nanomotor that can convert electrical energy into mechanical motion on a scale 500 times smaller than a grain of salt.

Mechanical engineering assistant professor Donglei “Emma” Fan led a team of researchers in the successful design, assembly and testing of a high-performing nanomotor in a nonbiological setting. The team’s three-part nanomotor can rapidly mix and pump biochemicals and move through liquids, which is important for future applications. The team’s study was published in the April issue of Nature Communications.

Fan and her team are the first to achieve the extremely difficult goal of designing a nanomotor with large driving power.

With all its dimensions under 1 micrometer in size, the nanomotor could fit inside a human cell and is capable of rotating for 15 continuous hours at a speed of 18,000 RPMs, the speed of a motor in a jet airplane engine. Comparable nanomotors run significantly more slowly, from 14 RPMs to 500 RPMs, and have only rotated for a few seconds up to a few minutes.

Looking forward, nanomotors could advance the field of nanoelectromechanical systems (NEMS), an area focused on developing miniature machines that are more energy efficient and less expensive to produce. In the near future, the Cockrell School researchers believe their nanomotors could provide a new approach to controlled biochemical drug delivery to live cells.

Mechanical engineering assistant professor Donglei "Emma" Fan

To test its ability to release drugs, the researchers coated the nanomotor’s surface with biochemicals and initiated spinning. They found that the faster the nanomotor rotated, the faster it released the drugs.

“We were able to establish and control the molecule release rate by mechanical rotation, which means our nanomotor is the first of its kind for controlling the release of drugs from the surface of nanoparticles,” Fan said. “We believe it will help advance the study of drug delivery and cell-to-cell communications.”

The researchers address two major issues for nanomotors so far: assembly and controls. The team built and operated the nanomotor using a patent-pending technique that Fan invented while studying at Johns Hopkins University. The technique relies on AC and DC electric fields to assemble the nanomotor’s parts one by one.

In experiments, the researchers used the technique to turn the nanomotors on and off and propel the rotation either clockwise or counterclockwise. The researchers found that they could position the nanomotors in a pattern and move them in a synchronized fashion, which makes them more powerful and gives them more flexibility.

Fan and her team plan to develop new mechanical controls and chemical sensing that can be integrated into nanoelectromechanical devices. But first they plan to test their nanomotors near a live cell, which will allow Fan to measure how they deliver molecules in a controlled fashion.

Cockrell School graduate students Kwanoh Kim, Xiaobin Xu and Jianhe Guo co-authored the study. The National Science Foundation Career Award, the Welch Foundation and startup funds from the Cockrell School supported the study.

http://www.engr.utexas.edu/features/nanomotors

Nanomotors Are Controlled, for the First Time, Inside Living Cells

For the first time, a team of chemists and engineers at Penn State University have placed tiny synthetic motors inside live human cells, propelled them with ultrasonic waves and steered them magnetically. It's not exactly "Fantastic Voyage," but it's close. The nanomotors, which are rocket-shaped metal particles, move around inside the cells, spinning and battering against the cell membrane.

"As these nanomotors move around and bump into structures inside the cells, the live cells show internal mechanical responses that no one has seen before," said Tom Mallouk, Evan Pugh Professor of Materials Chemistry and Physics at Penn State. "This research is a vivid demonstration that it may be possible to use synthetic nanomotors to study cell biology in new ways. We might be able to use nanomotors to treat cancer and other diseases by mechanically manipulating cells from the inside. Nanomotors could perform intracellular surgery and deliver drugs noninvasively to living tissues."

The researchers' findings will be published in Angewandte Chemie International Edition on 10 February 2014. In addition to Mallouk, co-authors include Penn State researchers Wei Wang, Sixing Li, Suzanne Ahmed, and Tony Jun Huang, as well as Lamar Mairof Weinberg Medical Physics in Maryland U.S.A.

The interaction between gold nanorods and HeLa cells in acoustic fields showing strong attachment. Videos play at original speed, and were taken under 500Xoverall magnification in dark field. Duration: 17 seconds. Credit: Mallouk Lab, Penn State University.

Up until now, Mallouk said, nanomotors have been studied only "in vitro" in a laboratory apparatus, not in living human cells. Chemically powered nanomotors first were developed ten years ago at Penn State by a team that included chemistAyusman Sen and physicist Vincent Crespi, in addition to Mallouk. "Our first-generation motors required toxic fuels and they would not move in biological fluid, so we couldn't study them in human cells," Mallouk said. "That limitation was a serious problem." When Mallouk and French physicistMauricio Hoyos discovered that nanomotors could be powered by ultrasonic waves, the door was open to studying the motors in living systems.

The assembly of a rotating HeLa cell/gold rod aggregate at an acoustic nodal line in the xy plane. The video was taken under 500X overall magnification except for 00:23 - 00:32 and 01:16 - 01:42, where a 200X overall magnification was used. Duration: 2:49. Credit: Mallouk Lab, Penn State University.

 

For their experiments, the team uses HeLa cells, an immortal line of human cervical cancer cells that typically is used in research studies. These cells ingest the nanomotors, which then move around within the cell tissue, powered by ultrasonic waves. At low ultrasonic power, Mallouk explained, the nanomotors have little effect on the cells. But when the power is increased, the nanomotors spring into action, moving around and bumping into organelles -- structures within a cell that perform specific functions. The nanomotors can act as egg beaters to essentially homogenize the cell's contents, or they can act as battering rams to actually puncture the cell membrane.

A demonstration of very active gold nanorods internalized inside HeLa cells in an acoustic field. This video was taken under 1000X magnification in the bright field, with most of the incoming light blocked at the aperture. Credit: Mallouk Lab, Penn State University.

While ultrasound pulses control whether the nanomotors spin around or whether they move forward, the researchers can control the motors even further by steering them, using magnetic forces. Mallouk and his colleagues also found that the nanomotors can move autonomously -- independently of one another -- an ability that is important for future applications. "Autonomous motion might help nanomotors selectively destroy the cells that engulf them," Mallouk said. "If you want these motors to seek out and destroy cancer cells, for example, it's better to have them move independently. You don't want a whole mass of them going in one direction."

The ability of nanomotors to affect living cells holds promise for medicine, Mallouk said. "One dream application of ours is Fantastic Voyage-style medicine, where nanomotors would cruise around inside the body, communicating with each other and performing various kinds of diagnoses and therapy. There are lots of applications for controlling particles on this small scale, and understanding how it works is what's driving us."

The research was funded by the National Science Foundation (MRSECgrant DMR-0820404), the National Institutes of Health, the Huck Innovative and Transformative Seed Fund (HITS) and Penn State University.

CONTACTS
Tom Mallouk: tem5@psu.edu, (+1) 814-863-9637
Barbara Kennedy (PIO): science@psu.edu, (+1) 814-863-4682

Source: http://science.psu.edu/news-and-events/2014-news/Mallouk2-2014